Introduction Rheumatoid arthritis (RA) affects 0.5–1% of people and causes chronic joint inflammation and damage.

Introduction Rheumatoid arthritis (RA) is an autoimmune disorder characterized by joint pain, swelling, and long-term

Introduction Interleukin-6 (IL-6) is a key cytokine driving inflammation across multiple organ systems. Sarilumab (SAR),

Introduction The treatment of autoimmune rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis,

Introduction Inflammatory arthritis encompasses a range of immune-mediated joint disorders such as rheumatoid arthritis (RA)

Introduction Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes persistent joint inflammation, leading

Introduction Tocilizumab (TCZ), a monoclonal antibody targeting the IL-6 receptor, has become a cornerstone therapy

Introduction Healthcare inequality remains a significant challenge, affecting treatment access and clinical outcomes for various

Introduction High-throughput technologies have revolutionized the understanding of rheumatoid arthritis (RA), revealing new molecular and

Introduction Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation in the joints,

Introduction Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting about 1% of the population,

Introduction (Article introduction authored by Conquest Editorial Team) Seropositive rheumatoid arthritis (RA) arises from a

Introduction (Article introduction authored by Conquest Editorial Team) A clinical practice guideline (CPG) was developed

Introduction (Article introduction authored by Conquest Editorial Team) A variety of disease-modifying antirheumatic drugs (DMARDs)

Introduction (Article introduction authored by Conquest Editorial Team) Rheumatoid arthritis (RA) poses a diagnostic challenge

Introduction (Article introduction authored by Conquest Editorial Team) In recent years, significant strides have been

Introduction (Article introduction authored by Conquest Editorial Team) Over the past two decades, treatment options

Introduction Rheumatoid arthritis (RA) stands as a multifaceted autoimmune disorder marked by persistent inflammation impacting

Introduction Chronic anterior uveitis is a concern in up to 20% of children with juvenile

Introduction Rheumatoid arthritis (RA) is a chronic and inflammatory autoimmune disease that affects elderly individuals

Introduction Rheumatoid arthritis is an immune disorder that causes joint inflammation and damage, often leading

Introduction Janus kinase inhibitors (JAKis) are a class of drugs that differ from biologics in

Introduction Rheumatoid arthritis (RA) is an autoimmune disease that affects multiple joints symmetrically and can

Introduction The last few decades have seen major therapeutic advancements in rheumatoid arthritis (RA) therapeutics.

Introduction Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by synovial inflammation, bone

Abstract Rheumatoid arthritis (RA) is an autoimmune inflammatory disease that mostly affects the synovial joints.

Introduction Rheumatoid arthritis (RA) is a chronic condition characterised by periods of remission alternated with

Abstract In the treatment of rheumatoid arthritis (RA), Janus kinase inhibitors (jakinibs) represent an emerging

Abstract Rheumatoid arthritis (RA) is a joint-related autoimmune disease that is difficult to cure. Most

Introduction Treatments used for rheumatoid arthritis (RA) are under investigation for their efficacy to prevent

Introduction In a biopsy-based, precision-medicine, randomized clinical trial in RA (R4RA; n = 164), patients

Introduction (Article introduction authored by Conquest Editorial Team) Rheumatoid arthritis (RA) is an autoimmune-mediated inflammatory

Introduction (Article introduction authored by Conquest Editorial Team) This review explores the crucial role of